Science and Enterprise

Tag: equity

  • Investments Added to Breakout Labs Life Science Seed Grants

    26 March 2014. NetScientific in Cambridge, U.K. is adding investment funds for qualified life science enterprises taking part in Breakout Labs to help them advance beyond the initial start-up phase. Under the deal, Breakout Labs portfolio companies fitting into NetScientific’s investment priorities will qualify for $250,000 in follow-on investment beyond Breakout Labs’ $350,000 in seed…

  • Bristol-Myers Squibb, Biotech in Cancer Drug Discovery Deal

    17 March 2014. Bristol-Myers Squibb, a pharmaceutical company in New York, and Five Prime Therapeutics in South San Francisco, California are collaborating in discovery of cancer immunotherapies. The deal can be worth as much as $350 million to Five Prime Therapeutics, in which Bristol-Myers Squibb will also get a 5 percent stake. Five Prime Therapeutics…

  • Smartphone Obstetrics App Gains $2M Angel, Public Funding

    10 March 2014. LionsGate Technologies, a medical device developer in Vancouver, British Columbia, received $2 million in private and public financing for its smartphone app measuring blood oxygen levels in pregnant women. The funds will support clinical trials and scaling up for production of LionsGate’s Phone Oximeter, a device that checks for risks of developing high blood pressure…

  • Life Sciences Investment Company Closes New Fund

    28 February 2014. Abingworth LLP, an investment company based in London, closed its 10th fund designed for financing life sciences and health care enterprises. The company says its Abingworth Bioventures VI fund raised £225 million ($375 million), exceeding its target of £200 million. Abingworth expects its Bioventures VI fund to invest in life sciences companies in Europe…

  • UCLA Starts Crowdfunding Platform for Research, Service

    18 February 2014. University of California at Los Angeles today started a crowdfunding platform to finance research and service projects by faculty and students. The platform, called UCLA Spark, began with five appeals including research projects in engineering and public health. Crowdfunding, according to the technology Web site Mashable, “describes the collective effort of individuals who…

  • Science-Based Enterprises: Great Ideas Beat Venture Capital

    14 February 2014. Three entrepreneurs starting companies based on science described how they got their businesses off the ground, with ground-breaking science in many cases more important than a large stash of venture capital. San Diego entrepreneurs John Newsam, Irwin Jacobs, and Han Cao told of their start-up business experiences today at a session of…

  • Start-Up Developing Gene Therapies Lands $45M in Early Funds

    12 February 2014. Voyager Therapeutics, a new start-up in Cambridge, Massachusetts creating gene therapies for disorders of the central nervous system, gained $45 million in first-round financing. Third Rock Ventures, a venture capital company specializing in life science enterprises, provided the funds for the company founded by researchers at University of Massachusetts Medical School, University…

  • Myriad Genetics Acquires Rheumatoid Arthritis Test Developer

    Myriad Genetics Inc., a designer of genetics-based diagnostics in Salt Lake City, will acquire Crescendo Bioscience in South San Francisco, California, a developer of molecular blood tests for autoimmune diseases, particularly rheumatoid arthritis. Myriad is paying $270 million in cash, which includes repayment of an outstanding $25 million loan to Crescendo. Crescendo Bioscience, founded in…

  • Pain Therapy Developer Issues IPO, Raises $55 Million

    31 January 2014. Cara Therapeutics Inc., a biotechnology company in Shelton, Connecticut, issued its initial public offering (IPO), raising some $55 million. The company issued 5 million shares of common stock, priced in the range of $11 to $13 a share. At noon ET today, the stock is priced at $13.38 a share on the…

  • Becton Dickinson Acquires Point-of-Care Diagnostics Maker

    Becton, Dickinson and Company, a medical device manufacturer in Franklin Lakes, New Jersey is buying Alverix Inc., a developer of point-of-care diagnostics equipment in San Jose, California. The purchase price is $40 million, according to a Becton Dickinson statement. Alverix designs testing equipment for physician’s offices, retail and mobile clinics, rural settings, and homes that…